Showing results (41-50 of 1,915) with videos related to

Sort By:
Pageof 192
CNS & Neurological Disorders Drug Targets|May 30, 2015
Poly(ADP)-Ribose Polymerase-1 Inhibitors as a Potential Treatment for Cocaine AddictionKimberly N Scobie
CNS & Neurological Disorders Drug Targets|May 30, 2015
Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant DependenceXia Li, Athina Markou
CNS & Neurological Disorders Drug Targets|January 27, 2025
Epigenetic Threads of Neurodegeneration: TFAM's Intricate Role in Mitochondrial TranscriptionAishwarya Bharathi H M, Prabitha Prabhakaran, Logesh Rajan, et al.
CNS & Neurological Disorders Drug Targets|December 6, 2024
The Potential Role of Dopamine Pathways in the Pathophysiology of Depression: Current Advances and Future AspectsArzoo Pannu, Ramesh K Goyal
CNS & Neurological Disorders Drug Targets|February 25, 2025
Fluoride-induced Neurodevelopmental Toxicity- AMPK as a Possible TargetTejas Ahuja, Farmiza Begum, Fathima Beegum, et al.
CNS & Neurological Disorders Drug Targets|October 30, 2024
Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's DiseaseParneet Kaur, Heena Khan, Amarjot Kaur Grewal, et al.
CNS & Neurological Disorders Drug Targets|November 4, 2025
Impact of Structured Physical Exercise on Adolescent Depression: A Comprehensive Meta-Analysis of RCTsJuliene Sá, Alberto Sá Filho, Adriana Meira G Chiappa, et al.
CNS & Neurological Disorders Drug Targets|October 15, 2025
Drug Design for Cerebral Ischemia: A Molecular Perspective ReviewDilay Kahvecioglu
CNS & Neurological Disorders Drug Targets|October 6, 2025
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment ApproachesUma Agarwal, Swati Paliwal, Vivek Yadav, et al.
CNS & Neurological Disorders Drug Targets|January 3, 2020
Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naï ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory CytokinesHussein Kadhem Al-Hakeim, Ahmed Jasim Twayej, Arafat Hussein Al-Dujaili, et al.
Pageof 192